Cargando…
2754. Phase 1 Trial of an mRNA-Based Combination Vaccine Against hMPV and PIV3
BACKGROUND: Human metapneumovirus (hMPV) and parainfluenza virus type 3 (PIV3) are important causes of upper and lower respiratory tract infections, particularly in young children. Despite their public health impact, no effective therapeutic or preventive options are available. mRNA-1653 is a mRNA-b...
Autores principales: | Shaw, Christine, Lee, Heather, Knightly, Conor, Kalidindi, Shiva, Zaks, Tal, Smolenov, Igor, Panther, Lori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810238/ http://dx.doi.org/10.1093/ofid/ofz360.2431 |
Ejemplares similares
-
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults
por: August, Allison, et al.
Publicado: (2022) -
hMPV Lineage Nomenclature and Heparin Binding
por: Adamson, Penelope, et al.
Publicado: (2013) -
Molecular epidemiology of human metapneumovirus (hMPV) in Cambodia
por: Arnott, Alicia, et al.
Publicado: (2011) -
Host Components That Modulate the Disease Caused by hMPV
por: Gálvez, Nicolás M. S., et al.
Publicado: (2021) -
Human Metapneumovirus (hMPV) Infection and MPV467 Treatment in Immunocompromised Cotton Rats Sigmodon hispidus
por: Yim, Kevin C., et al.
Publicado: (2023)